December 05, 2016 10:06 AM ET

Biotechnology

Company Overview of Kylin Therapeutics, Inc.

Key Executives for Kylin Therapeutics, Inc.

NameBoard RelationshipsTitleAge
J. Eric Davis J.D.6 RelationshipsChief Executive Officer, President and Director--
Peixiuan Guo Ph.D.6 RelationshipsFounder and Chairman of the Scientific Advisory Board--
Joseph P. Trebley Ph.D.No RelationshipsDirector of Technology Development--
Henry Li No RelationshipsDirector of Research and Development Team--

Kylin Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
J. Eric Davis J.D. 6 RelationshipsKylin Therapeutics, Inc.--
Peixiuan Guo Ph.D. 6 RelationshipsKylin Therapeutics, Inc.--
Homer L. Pearce Ph.D. 73 RelationshipsPearl Street Venture Funds63
Olke C. Uhlenbeck Ph.D. 6 RelationshipsKylin Therapeutics, Inc.--
David Johnston Ph.D. 10 RelationshipsPharmaceutical Product Development, LLC--
View All Board Members

Kylin Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Peixiuan Guo6 Relationships6 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
375.8K
Bonus
254.9K
Total Short Term Compensation
468.1K
Total Value of Options
33.7M
Compensation as of Fiscal Year
Kylin Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Tonix Pharmaceuticals Holding Corp. Announces Resignation of Bruce Daugherty as Chief Scientific Officer Controller and Secretary, Effective December 31, 2016
December 02, 2016 9:31 PM ET
Alkermes plc Announces Resignation of Gordon G. Pugh as the Senior Vice President, Chief Operating Officer and Chief Risk Officer, Effective January 3, 2017
December 02, 2016 9:30 PM ET
Oasmia Pharmaceutical AB Announces Executive Changes
December 02, 2016 3:05 PM ET
CytRx Corporation Appoints Earl Warren Brien to its Board of Directors
December 02, 2016 2:00 PM ET
Vertex Pharmaceuticals Incorporated Announces Executive Appointments
December 02, 2016 1:42 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kylin Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.